作者:Bei-Dou Zhou、Li-Lan Zeng、Yu-Gui Tong、Jia-Ying Fang、Zhi-Peng Ruan、Xiao-Yun Zeng、Yuan-Yuan Fang、Gui-Fen Xu、Dong-Bao Hu
DOI:10.1080/10286020.2018.1454437
日期:2018.5.4
compounds’ in vitro anti-proliferative activities against nine human cancer cell lines, antityrosinase, and antioxidant activities were evaluated. Compounds 1, 4, 6–7, and 9–10 exhibited enhanced cytotoxicity against certain cancer cells. Compounds 2, 8, 9, and 10 inhibited tyrosinase activity to a certain extent. In addition, compound 4 exhibited the best antioxidant activity, which was consistent with theoretical
一步合成十个取代的1,3-二羟基黄嘌呤。产率为40%至76%。化合物8 - 10为首次报道。接下来,评估了这些化合物对9种人类癌细胞系的体外抗增殖活性,抗酪氨酸酶和抗氧化活性。化合物1,4,6 - 7,和9 - 10表现出增强的对某些癌细胞的细胞毒性。化合物2,8,9,和10抑制酪氨酸酶活性在一定程度上。另外,化合物4表现出最好的抗氧化活性,这与理论计算相符。这些结果表明,化合物1 - 2,4,和6 - 10是有希望用于进一步研究引线。